Morgantown, W.Va.-based WVU Medicine Cancer Institute and Ann Arbor-based Michigan Medicine are participating in the world’s first in-human phase 1 clinical trial of an electric implant for the treatment of pancreatic cancer.
The small, implantable device delivers chemotherapy directly into pancreatic tissue through low-voltage electric pulses, according to a May 20 news release from WVU Medicine.
The trial is enrolling patients with nonmetastatic, locally advanced, unresectable pancreatic cancer, the release said.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
